Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021

Rhea-AI Summary

Hancock Jaffe Laboratories, a developer of medical devices, will host a corporate update conference call on September 21, 2021, at 4:30 p.m. ET. Management will discuss the ongoing development of VenoValve and other corporate initiatives. The call will be led by Robert Berman, CEO, and Dr. Marc Glickman, CMO. Interested parties can participate by calling (877) 407-9708 (domestic) or (201) 689-8259 (international). The live webcast will be available on Hancock Jaffe's Investors section of their website, archived for 90 days.

Conference call with live video webcast to be held on Tuesday, September 21^st at 4:30 p.m. ET

IRVINE, CA / ACCESSWIRE / September 15, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a developer of medical devices that restore cardiac and vascular health, today announced that Hancock Jaffe management will host a corporate update conference call with a live video webcast on Tuesday, September 21, 2021 at 4:30 p.m. ET.

As part of the call, management will discuss VenoValve's continued development and other ongoing corporate initiatives. The call will be led by Robert Berman, Chief Executive Officer of Hancock Jaffe, who will be joined by Dr. Marc Glickman, Chief Medical Officer of Hancock Jaffe. Interested participants and investors may access the conference call by dialing (877) 407-9708 (domestic) or (201) 689-8259 (international). The live webcast will be accessible on the IR Calendar page of the Investors section of the Hancock Jaffe website, www.hancockjaffe.com, and will be archived for 90 days.

About Hancock Jaffe Laboratories, Inc.

Hancock Jaffe Laboratories (NASDAQ:HJLI) specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValve®, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraft®, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.

INVESTOR CONTACT:

Jenene Thomas, JTC Team, LLC
HJLI@jtcir.com
(833) 475-8247

MEDIA CONTACT:

Michelle McAdam, Chronic Communications, Inc.
michelle@chronic-comm.com
(310) 902-1274

SOURCE: Hancock Jaffe Laboratories, Inc.

View source version on accesswire.com:
https://www.accesswire.com/664103/Hancock-Jaffe-to-Host-Corporate-Update-Conference-Call-and-Webcast-on-September-21-2021

FAQ

What is Hancock Jaffe Laboratories planning to discuss on September 21, 2021?

Hancock Jaffe Laboratories will discuss the development of VenoValve and other ongoing corporate initiatives during their corporate update conference call.

How can I access the Hancock Jaffe conference call on September 21, 2021?

You can access the Hancock Jaffe conference call by dialing (877) 407-9708 for domestic calls or (201) 689-8259 for international calls.

Who will lead the Hancock Jaffe conference call on September 21, 2021?

The conference call will be led by Robert Berman, the CEO, along with Dr. Marc Glickman, the CMO of Hancock Jaffe.

What time is the Hancock Jaffe conference call scheduled for?

The Hancock Jaffe conference call is scheduled for September 21, 2021, at 4:30 p.m. ET.

Where can I find the live webcast for the Hancock Jaffe conference call?

The live webcast for the Hancock Jaffe conference call will be accessible on the Investors section of their website.